MV-anti-PD1

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameMV-anti-PD1

Drug Alias NamePD-1 checkpoint inhibitor (Deutsches Krebsforschungszentrum)measles virus vector-based anti-PD-1 antibody (Deutsches Krebsforschungszentrum)

ClassificationBiologics > Oncolytic virusBiologics > Protein drugs > Immunoglobulin > Antibody

Mechanisms of ActionProgrammed cell death protein 1 blockers

TargetsProgrammed cell death protein 1

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGerman Cancer Research Center (Dkfz)

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGerman Cancer Research Center (Dkfz)

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A